Evidence map›Paper›PMID 33456525›Full record

ArticleExperimental and therapeutic medicine2021

Reciprocal regulation of interleukin-17A and interleukin-22 secretion through aryl hydrocarbon receptor activation in CD4

Baoyi Liu, Yongyi Xie, Xingyu Mei, Yue Sun, Weimin Shi, Zhouwei Wu

Open access · diamondAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Experimental and therapeutic medicine, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed, 1 pooled it
0.4field-weighted citation impact, top 40% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 1 synthesis or guideline pooled it, 10 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Review
  5. Review
  6. Review
  7. Article
  8. Article
  9. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Baoyi LiuDepartment of Dermatology, Shanghai General Hospital, Shanghai Jiaotong University, Shanghai 200080, P.R. China.
Yongyi XieDepartment of Dermatology, Shanghai General Hospital, Shanghai Jiaotong University, Shanghai 200080, P.R. China.
Xingyu MeiDepartment of Dermatology, Shanghai General Hospital, Shanghai Jiaotong University, Shanghai 200080, P.R. China.
Yue SunDepartment of Dermatology, Shanghai General Hospital, Shanghai Jiaotong University, Shanghai 200080, P.R. China.
Weimin ShiDepartment of Dermatology, Shanghai General Hospital, Shanghai Jiaotong University, Shanghai 200080, P.R. China.
Zhouwei WuDepartment of Dermatology, Shanghai General Hospital, Shanghai Jiaotong University, Shanghai 200080, P.R. China.
Shanghai First People's Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Previous studies have shown the participation of the cytokines interleukin (IL) 17A and IL22 in the development of vitiligo. The aryl hydrocarbon receptor (AhR) functions in the pathogenesis of vitiligo and can modulate cytokine production. The aim of the present study was to determine the relationship between AhR activation and the secretion of IL17A and IL22 in CD4

Indexed as

aryl hydrocarbon receptorGinkgo bilobainterleukin 17Ainterleukin 22vitiligo

Identifiers

PMID33456525
PMCPMC7792475
OpenAlexW3112889966

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.